- Home
- ABL vs ORGO Comparison
ABL vs ORGO Comparison
Compare ABL & ORGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABL
- ORGO
- Stock Information
- Founded
- ABL 2004
- ORGO 1985
- Country
- ABL United States
- ORGO United States
- Employees
- ABL N/A
- ORGO N/A
- Industry
- ABL Investment Managers
- ORGO Biotechnology: Pharmaceutical Preparations
- Sector
- ABL Finance
- ORGO Health Care
- Exchange
- ABL Nasdaq
- ORGO Nasdaq
- Market Cap
- ABL 521.6M
- ORGO 465.6M
- IPO Year
- ABL N/A
- ORGO N/A
- Fundamental
- Price
- ABL $4.83
- ORGO $4.49
- Analyst Decision
- ABL Strong Buy
- ORGO Hold
- Analyst Count
- ABL 4
- ORGO 1
- Target Price
- ABL $13.13
- ORGO $6.00
- AVG Volume (30 Days)
- ABL 1.1M
- ORGO 882.7K
- Earning Date
- ABL 08-11-2025
- ORGO 08-07-2025
- Dividend Yield
- ABL N/A
- ORGO N/A
- EPS Growth
- ABL N/A
- ORGO N/A
- EPS
- ABL N/A
- ORGO N/A
- Revenue
- ABL $134,575,948.00
- ORGO $458,760,000.00
- Revenue This Year
- ABL $68.84
- ORGO $1.10
- Revenue Next Year
- ABL $26.84
- ORGO $9.93
- P/E Ratio
- ABL N/A
- ORGO N/A
- Revenue Growth
- ABL 73.39
- ORGO 5.35
- 52 Week Low
- ABL $4.60
- ORGO $2.28
- 52 Week High
- ABL $11.86
- ORGO $6.71
- Technical
- Relative Strength Index (RSI)
- ABL 31.28
- ORGO 68.17
- Support Level
- ABL $5.06
- ORGO $3.59
- Resistance Level
- ABL $5.68
- ORGO $4.70
- Average True Range (ATR)
- ABL 0.30
- ORGO 0.23
- MACD
- ABL 0.05
- ORGO 0.09
- Stochastic Oscillator
- ABL 21.32
- ORGO 85.36
About ABL Abacus Life Inc.
Abacus Global Management Inc is a financial services company specializing in alternative asset management, data-driven wealth solutions, technology innovations, and institutional services. The Company organizes its business into five reportable segments Active Management, Originations, Asset Management, Portfolio Servicing, and Technology Services. Its operations are confined to the United States.
About ORGO Organogenesis Holdings Inc.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.